March 17, 2014 / 8:05 AM / in 4 years

BRIEF-Lundbeck, Otsuka launches schizophrenia drug in Europe

COPENHAGEN, March 17 (Reuters) - Danish pharmaceutical company H Lundbeck A/S said on Monday: * Schizophrenia drug Abilify Maintena is now available in a number of European countries * Denmark is the first European country where Abilify Maintena is fully reimbursed * More than ten markets are expected to launch Abilify Maintena by the end of 2014

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below